Event Type: Post-results conference call with analysts/investors to discuss business strategy and outlook following Q2 FY27 unaudited financial results declaration.
Date and Time: Thursday, 5th November 2026 at 4:00 PM IST (India Standard Time).
Time Zone Conversions: The call is scheduled for 6:30pm Hong Kong/Singapore time, 11:30am UK time, and 6:30am New York time.
Management Participants: The conference call will feature:
Mr. Mohan Goenka – Wholetime Director & Vice Chairman
Mr. Vivek Dhir – CEO (International Business)
Mr. Dhruv Aggarwal – Chief Growth Officer
Mr. Gul Raj Bhatia – President (Healthcare)
Mr. Manish Gupta – President (Sales)
Mr. Rajesh Sharma – President (Finance & IR)
Regulatory Context: The intimation is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Period: The call will discuss Q2 FY27 (Second Quarter of Financial Year 2026-2027) unaudited financial results.
Additional Notes
Contact Information: For further information, participants can contact:
Compliance: The document is a regulatory filing submitted to both National Stock Exchange of India Ltd. and BSE Limited on 26th October, 2026, signed by N.H. Bhansali, CEO- Finance, Strategy & Business Development and CFO of Emami Limited.
Financial Data: No specific financial figures or performance metrics were disclosed in this announcement. The call will discuss results that have already been declared.
